cisにおける二重PIK3CA変異は,PI3Kα阻害剤に対する腫瘍性および敏感性を増加させる.
PubMedで要約を見る
まとめ
この要約は機械生成です。癌における複数のPIK3CA変異,特に二重変異はPI3K経路の活性を増強する. これらの発見は,二重のPIK3CA変異を持つ患者がPI3Kα阻害剤による治療からより多くの利益を得ることを示唆しています.
科学分野
- 腫瘍学
- 分子生物学
- 遺伝学
背景
- PIK3CAの活性化突然変異は乳がんにおいて一般的です.
- フォスホイノシチド3キナーゼα (PI3Kα) 阻害剤は,特定の癌の治療法として承認されています.
- PIK3CA変異の状態を理解することは,治療への反応を予測するのに極めて重要です.
研究 の 目的
- 多数のPIK3CA変異の流行と機能的影響を調査する.
- PI3Kα阻害剤に対する感受性の決定因子を特定する.
- 単一のPIK3CA変異とダブルPIK3CA変異の効果を比較する.
主な方法
- PIK3CA変異がんの遺伝子解析
- PI3Kの活性とシグナリングを評価する生化学的測定法
- 細胞増殖と腫瘍増殖の評価
- 変異状態に基づくPI3Kα阻害剤に対する敏感性の比較
主要な成果
- 分析されたがんの12~15%には複数のPIK3CA変異があり,主に同じアレル (cis) の二重変異がある.
- 二重のPIK3CA変異は,PI3Kの活性が増加し,下流信号伝達が強化され,細胞増殖と腫瘍の成長が加速されます.
- 生化学的メカニズムは,p110α / p85α結合の障害とp110α膜脂質結合の増加を含む.
- 二重のPIK3CA変異は,単一のホットスポット変異と比較して,PI3Kα阻害剤に対する感受性の増加と関連しています.
結論
- 多数のPIK3CA変異は重要な腫瘍発生現象を表しています.
- PIK3CAの二重変異の存在は,腫瘍信号と腫瘍の成長を高めます.
- 二重PIK3CA変異を有する患者は,PI3Kα阻害剤に対する感受性が高くなり,潜在的な治療分層化を示唆する.
関連する概念動画
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...

